Myriad Genetics Inc (MYGN)
13.66
+0.01
(+0.07%)
USD |
NASDAQ |
Dec 24, 12:32
Myriad Genetics Market Cap: 1.244B for Dec. 24, 2024
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Haemonetics Corp | 3.877B |
| Boston Scientific Corp | 133.81B |
| Globus Medical Inc | 11.32B |
| ResMed Inc | 33.96B |
| Perspective Therapeutics Inc | 216.28M |
Market Cap Related Metrics
| PS Ratio | 1.484 |
| Price to Book Value | 1.700 |
| Price | 13.66 |
| Earnings Yield | -9.52% |